LENTIHERO Trademark

Trademark Overview


On Friday, September 23, 2022, a trademark application was filed for LENTIHERO with the United States Patent and Trademark Office. The USPTO has given the LENTIHERO trademark a serial number of 97604122. The federal status of this trademark filing is FINAL REFUSAL - MAILED as of Friday, July 26, 2024. This trademark is owned by ASTREA UK SERVICES LIMITED. The LENTIHERO trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:

Proteins for medical diagnostic purposes; enzymes for medical use; viral particles for medical use; proteins, namely viral particles for medical use; medical and clinical diagnostic reagents; insulin and insulin analogues

Nanofiber filtering compositions for viral particle purification; nanofiber filtering materials for viral particle purification; filtering materials for viral particle purification of chemical and biological substances;chromatographic media for purification of viral particles; filtering media for chromatographic purification of substances comprising of chemicals and biologicals; chemical and biological absorbents and adsorbents for recovery of viral particles for viral vector development; chemical and biological purifying agents for chromatographic purification of chemical and biological preparations; chemicals and biologicals for use in bioseparation for viral particle purification; chemicals and biologicals for use in filtering for viral particle purification; chemical and biological substances for use in separation for viral particle purification; fibres of inorganic material for separation purposes for viral particle purification; fibres of organic material for separation purposes ...
lentihero

General Information


Serial Number97604122
Word MarkLENTIHERO
Filing DateFriday, September 23, 2022
Status645 - FINAL REFUSAL - MAILED
Status DateFriday, July 26, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesProteins for medical diagnostic purposes; enzymes for medical use; viral particles for medical use; proteins, namely viral particles for medical use; medical and clinical diagnostic reagents; insulin and insulin analogues
Goods and ServicesNanofiber filtering compositions for viral particle purification; nanofiber filtering materials for viral particle purification; filtering materials for viral particle purification of chemical and biological substances;chromatographic media for purification of viral particles; filtering media for chromatographic purification of substances comprising of chemicals and biologicals; chemical and biological absorbents and adsorbents for recovery of viral particles for viral vector development; chemical and biological purifying agents for chromatographic purification of chemical and biological preparations; chemicals and biologicals for use in bioseparation for viral particle purification; chemicals and biologicals for use in filtering for viral particle purification; chemical and biological substances for use in separation for viral particle purification; fibres of inorganic material for separation purposes for viral particle purification; fibres of organic material for separation purposes for viral particle purification; raw proteins for scientific and medical research; proteins for scientific and industrial use; enzymes for scientific and industrial use, reagents for scientific and research use other than for medical use; ligands for scientific and research use; biochemical, namely, antibodies and antibody fragments for in vitro scientific or research use

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateTuesday, October 11, 2022
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, October 11, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameASTREA UK SERVICES LIMITED
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressComberton, Cambridge CB237AJ
GB

Trademark Events


Event DateEvent Description
Saturday, June 24, 2023ASSIGNED TO EXAMINER
Tuesday, September 27, 2022NEW APPLICATION ENTERED
Tuesday, October 11, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, July 14, 2023NON-FINAL ACTION WRITTEN
Friday, July 14, 2023NON-FINAL ACTION E-MAILED
Friday, July 14, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, October 13, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, October 13, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, October 13, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 16, 2023SUSPENSION LETTER WRITTEN
Monday, October 16, 2023LETTER OF SUSPENSION E-MAILED
Monday, October 16, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, October 18, 2023TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, March 7, 2024ASSIGNED TO LIE
Friday, March 8, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 8, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, July 26, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, July 26, 2024FINAL REFUSAL WRITTEN
Friday, July 26, 2024FINAL REFUSAL E-MAILED